Danish drugmaker, Novo Nordisk, which has a plant in Monksland, is to lay off 9,000 of its staff worldwide. 5,000 of those redundancies are expected to come from its sites in Denmark as part of ...

While Pfizer's market cap and dividends are at risk, Novo has a strong competitive position in GLP-1 TAM. Read why I prefer ...

Orsted doesn’t weigh as heavily on Denmark’s economy as Novo, but its crisis runs deeper and strikes directly at the ...

Novo Nordisk, the maker of weight loss drug Wegovy, will lay off about 9,000 people as it grapples with rising competition in the obesity market.

By Jamie Ducharme, KFF Health News After losing 50 pounds on the injectable weight loss medication Zepbound, Kyra Wensley received a surprising letter from her pharmacy benefit manager in April. Her ...